Key terms
About RMTI
Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte. The company was founded by Robert L. Chioini in 1996 and is headquartered in Wixom, MI.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest RMTI news
Yesterday
6:02am ET
Rockwell Medical announces purchase agreement with large health system
Apr 04
6:02am ET
Rockwell Medical expands global distribution in Dominican Republic and Bermuda
Mar 25
6:30am ET
Analysts Offer Insights on Healthcare Companies: Rockwell Med (RMTI), Hookipa Pharma (HOOK) and Sagimet Biosciences, Inc. Class A (SGMT)
Mar 25
6:14am ET
Rockwell Medical price target lowered to $9 from $11 at H.C. Wainwright
Mar 22
3:55pm ET
Buy Rating Reaffirmed for Rockwell Med amidst Strategic Growth and Operational Efficiency
Mar 21
7:42am ET
Rockwell Medical Unveils Updated Corporate Insight Presentation
Mar 21
6:04am ET
Rockwell Medical reports Q4 adjusted EPS 2c vs. (3c) last year
Mar 18
8:00am ET
Options Volatility and Implied Earnings Moves This Week, March 18 – March 21, 2024
No recent press releases are available for RMTI
RMTI Financials
Key terms
Ad Feedback
RMTI Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
RMTI Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
